Kraton™ MD6953 MU is a linear styrene-ethylene/butylene-styrene block copolymer with a nominal styrene content of 33 wt%, density of 0.91 g/cm³ per ISO 1183-1:2019, and uncompounded Shore A hardness in the 60–70 range per ASTM D2240-15e1. Production-scale compounding of PVC-free infusion tubing compounds from this grade is normally executed on a co-rotating twin-screw extruder with an L/D ratio of 44:1 to 52:1. A starting-point formulation comprises 40–55 wt% Kraton™ MD6953 MU, 20–35 wt% medical-grade white oil, 10–20 wt% polypropylene homopolymer, 5–10 wt% high-density polyethylene, and 0.1–0.3 wt% of a phenolic-phosphite antioxidant package. The regulatory boundary for this compound falls under FDA 21 CFR 177.1810, with additional biocompatibility screening per ISO 10993-5:2009, ISO 10993-10:2010, ISO 10993-11:2017, and USP <88> Class VI. During compounding, low-molecular-weight hydrocarbon oil can phase-separate if screw speed exceeds 450 rpm on a 40 mm co-rotating twin-screw due to shear heating that drives melt temperature beyond 230 °C; this produces batch-to-batch Shore A variation greater than 3 points and is controlled with distributive mixing elements in zones 4–6 and vacuum devolatilisation at −0.08 MPa. Tube extrusion downstream uses a single-screw extruder with an L/D of 30:1, die temperature 210–220 °C, and cooling water at 10–15 °C. Terminal products include IV administration tubing, peristaltic pump tubing, and jacketing for dialysis lines. Compounds must be pre-dried at 80 °C for 2–4 h if exposed to ambient relative humidity above 60 %. Co-storage with DEHP-containing PVC line components is not recommended because plasticizer migration can lower tensile strength and generate tacky surfaces on coiled tubing.

What Changes When SEBS Replaces Thermoset Rubber in Prefilled Syringe Plunger Seals?

Injection molding of prefilled syringe plunger seals from Kraton™ MD6953 MU removes the sulfur-vulcanization and post-cure steps associated with halogenated butyl rubber. A production-validated starting composition uses 100 parts by mass Kraton™ MD6953 MU, 0.1–0.3 parts phenolic antioxidant, and optionally 10–20 parts polypropylene homopolymer when higher dimensional stability is required. The material is processed on a reciprocating-screw injection molding machine with a shot-residence ratio above 20 % of barrel capacity, barrel temperatures from 200 °C to 230 °C, and a cold-runner mold held at 30–50 °C. Holding pressure is set at 50–70 % of injection pressure, with injection pressure in the range 60–90 MPa. Plunger seal wall thicknesses of 1.2–3.0 mm require cooling times of 15–30 s. Regulatory expectations are defined by USP <381>, USP <88> Class VI, ISO 10993-5:2009, ISO 10993-10:2010, and ISO 11040-5:2012. Because SEBS contains no sulfur, accelerator, or zinc oxide cure system, extractable profiles differ from thermoset rubber closures; residual peroxide and amine crosslinker by-products are absent. The main process risk is void formation at the gate when melt temperature exceeds 240 °C, producing visual rejects under 2.5× magnification and irregular compression set. Maintaining melt temperature below 235 °C and installing a heated sprue bushing reduce reject rates. Terminal products include plunger seals, needle shields, and vial stopper liners for injectable drug packaging.

When Coextruded with Random Copolymer Polypropylene in Ostomy Barrier Film

In a three-layer cast film configuration, the sealant layer contains 70–85 wt% Kraton™ MD6953 MU, 10–20 wt% random copolymer polypropylene, and 5–15 wt% medical-grade white oil. The skin-contact layer is coextruded with a tie layer and an outer layer of polypropylene random copolymer at layer ratios of 60/10/30 to 75/5/20, depending on heat-seal strength and moisture vapour transmission targets. Standards governing this construction include ISO 10993-5:2009, ISO 10993-10:2010, and FDA 21 CFR 177.1520 for the polypropylene component, while ASTM E96/E96M-22 is used for water vapour transmission testing. Cast film processing is performed on a three-extruder line with screw diameters of 25 mm/35 mm/25 mm, die temperature 220–235 °C, and a polished chill roll held at 12–18 °C. Heat-seal activation occurs at 150–165 °C for 1.0–2.5 s; above 170 °C the sealant layer begins to thin and creates channel leakers. In production, migration of low-molecular-weight oil to the film surface is monitored by Fourier transform infrared spectroscopy at 7-day intervals because oil bloom above a surface concentration of 0.3 mg/100 cm² reduces pouch weld strength. Terminal products include ostomy pouch barrier films, wound drainage pouch inner liners, and faecal management devices. This film structure is not recommended for repeated autoclave sterilization because layer delamination occurs after more than 30 cycles at 134 °C.

Insert molding of soft-touch grips onto polypropylene-based surgical instrument handles uses a two-shot injection cell with a vertical rotary platen. The soft-touch compound is prepared from 45–60 wt% Kraton™ MD6953 MU, 10–25 wt% polypropylene homopolymer, and 20–30 wt% medical-grade white oil; the exact ratio within this envelope is adjusted to a target Shore A of 45–65 measured per ASTM D2240-15e1. The substrate is injection molded from polypropylene homopolymer at a melt temperature of 210–230 °C, transferred to the second cavity, and overmolded at 190–215 °C with a mold temperature of 30–45 °C. Because unmodified SEBS does not develop structural bond strength to polycarbonate, polyamide, or polyester substrates, adhesion is restricted to polyolefin substrates or else a maleic anhydride-grafted tie-layer must be used. Compliance verification for the overmolded assembly includes ISO 10993-5:2009, ISO 10993-10:2010, and 21 CFR 177.1810 for the styrenic block copolymer phase. Terminal products include ergonomic grips on powered surgical instruments, vibration-damping pads on diagnostic analyzers, and bumper components on wearable insulin pumps. Process audits on production lines show that cavity-pressure sensors reading below 35 MPa during overmold injection correlate with short shots at the distal tool end, and this is corrected by increasing holding pressure by 10–15 %.

Sterilisation Dose Mapping Identifies Tensile Retention Limits in Wound Care Film Laminates

Before release of wound dressing film laminates, dose mapping across 25 kGy, 40 kGy, and 50 kGy electron-beam or gamma irradiation is performed because phenolic antioxidant depletion changes tensile retention and yellowing. A cast film formulation for wound care backings uses 60–80 wt% Kraton™ MD6953 MU, 10–20 wt% polypropylene random copolymer, and 5–15 wt% aliphatic hydrocarbon oil. Film is cast at 220–240 °C onto a matt steel chill roll at 15–20 °C, with thickness controlled to 50–200 μm for incise drapes and wound-contact layers. Tensile strength and elongation are measured according to ASTM D882-18 before and after sterilization; supplier-published data for this specific Kraton™ MD6953 MU film configuration is limited, so lot-specific validation is required. Biocompatibility requirements include ISO 10993-5:2009, ISO 10993-10:2010, and ISO 11137-1:2006 for radiation sterilization validation. The main processing risk occurs when film thickness exceeds 300 μm, where electron-beam dose penetration becomes non-uniform and hard spots develop. Terminal products include wound dressing backing films, incision drape laminates, and medical tape backing layers.

Breathable Elastic Backsheet Film for Negative-Pressure Wound Therapy Dressing Systems

Microporosity in breathable elastic backsheet films is generated by machine-direction orientation of calcium carbonate-filled Kraton™ MD6953 MU compounds at stretch ratios between 2.5:1 and 4.0:1. The starting compound comprises 30–45 wt% Kraton™ MD6953 MU, 15–25 wt% polypropylene homopolymer, 30–50 wt% treated calcium carbonate, and 5–10 wt% medical-grade white oil. The filled compound is pelletized on a twin-screw extruder with an L/D of 44:1, then extruded as cast film with a die gap of 500–800 μm at 210–230 °C and oriented in-line through an MDO unit with roll temperatures ramped from 70 °C to 95 °C. This creates elongated micropores that increase moisture vapour transmission while maintaining hydrostatic head resistance. Compliance references for NPWT dressings include ISO 10993-5:2009, ISO 10993-10:2010, EN 13726-1:2002, and ASTM E96/E96M-22 for MVTR verification. Terminal products are microporous backsheet layers in negative-pressure wound therapy dressings, surgical fenestration films, and breathable cover layers for wearables. The operational boundary is that calcium carbonate loading above 50 wt% combined with orientation ratios above 4.0:1 produces film fibrillation, pinholes, and loss of bacterial barrier function. Batch-to-batch variation in calcium carbonate particle size distribution measured by laser diffraction must remain within ±0.5 μm of the specified D50 to maintain consistent pore dimensions.